Format
Sort by
Items per page

Send to

Choose Destination

Best matches for estrogens/AE AND Human[MH] AND (drug-induced liver injury OR jaundice/CI OR bile duct diseases/CI OR liver/DE OR liver diseases/CI OR hepatitis, toxic[MH]) AND ("2009/12/1"[EDat]:"2999/12/31"[EDat]):

Search results

Items: 13

1.

Environmental Xenoestrogens Super-Activate a Variant Murine ER Beta in Cholangiocytes.

Meyer SK, Probert PM, Lakey AK, Leitch AC, Blake LI, Jowsey PA, Cooke MP, Blain PG, Wright MC.

Toxicol Sci. 2017 Mar 1;156(1):54-71. doi: 10.1093/toxsci/kfw234.

2.

Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.

Zhong GC, Liu Y, Chen N, Hao FB, Wang K, Cheng JH, Gong JP, Ding X.

Hum Reprod Update. 2016 Dec;23(1):126-138. Epub 2016 Sep 21. Review.

PMID:
27655589
3.

Detection of differential DNA methylation in repetitive DNA of mice and humans perinatally exposed to bisphenol A.

Faulk C, Kim JH, Anderson OS, Nahar MS, Jones TR, Sartor MA, Dolinoy DC.

Epigenetics. 2016 Jul 2;11(7):489-500. doi: 10.1080/15592294.2016.1183856. Epub 2016 Jun 6.

4.

Risk of hormonotherapy in transgender people: Literature review and data from the French Database of Pharmacovigilance.

Bourgeois AL, Auriche P, Palmaro A, Montastruc JL, Bagheri H.

Ann Endocrinol (Paris). 2016 Feb;77(1):14-21. doi: 10.1016/j.ando.2015.12.001. Epub 2016 Jan 29. Review.

PMID:
26830952
5.

Estrogen-Induced Cholestasis Leads to Repressed CYP2D6 Expression in CYP2D6-Humanized Mice.

Pan X, Jeong H.

Mol Pharmacol. 2015 Jul;88(1):106-12. doi: 10.1124/mol.115.098822. Epub 2015 May 5.

6.

Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes.

Patlewicz G, Simon TW, Rowlands JC, Budinsky RA, Becker RA.

Regul Toxicol Pharmacol. 2015 Apr;71(3):463-77. doi: 10.1016/j.yrtph.2015.02.011. Epub 2015 Feb 20.

7.

Adenoviral transfer of human aquaporin-1 gene to rat liver improves bile flow in estrogen-induced cholestasis.

Marrone J, Lehmann GL, Soria LR, Pellegrino JM, Molinas S, Marinelli RA.

Gene Ther. 2014 Dec;21(12):1058-64. doi: 10.1038/gt.2014.78. Epub 2014 Sep 11.

PMID:
25208977
8.

Estrogen-induced cholestasis: pathogenesis and therapeuticimplications.

Chen J, Zhao KN, Liu GB.

Hepatogastroenterology. 2013 Sep;60(126):1289-96. doi: 10.5754/hge121061. Review.

PMID:
23933920
9.

[Nomegestrol acetate in contraception and venous thrombotic risk].

Jamin C.

Gynecol Obstet Fertil. 2012 Jul-Aug;40(7-8):394-5. doi: 10.1016/j.gyobfe.2012.03.007. Epub 2012 Jun 29. French. No abstract available.

PMID:
22749671
10.

Estrogen upregulates hepatic apolipoprotein M expression via the estrogen receptor.

Wei J, Shi Y, Zhang X, Feng Y, Luo G, Zhang J, Mu Q, Tang Y, Yu Y, Pan L, Nilsson-Ehle P, Xu N.

Biochim Biophys Acta. 2011 Dec;1811(12):1146-51. doi: 10.1016/j.bbalip.2011.07.003. Epub 2011 Jul 18.

PMID:
21816233
11.

Metabolic effects of contraceptive steroids.

Sitruk-Ware R, Nath A.

Rev Endocr Metab Disord. 2011 Jun;12(2):63-75. doi: 10.1007/s11154-011-9182-4. Review.

PMID:
21538049
12.

Giant liver hemangioma: the role of female sex hormones and treatment.

van Malenstein H, Maleux G, Monbaliu D, Verslype C, Komuta M, Roskams T, Laleman W, Cassiman D, Fevery J, Aerts R, Pirenne J, Nevens F.

Eur J Gastroenterol Hepatol. 2011 May;23(5):438-43. doi: 10.1097/MEG.0b013e328345c87d.

PMID:
21399504
13.

Supplemental Content

Loading ...
Support Center